Artiaga, B. L., Madden, D., Kwon, T., McDowell, C., Keating, C., Balaraman, V., . . . Driver, J. P. Adjuvant Use of the Invariant-Natural-Killer-T-Cell Agonist α-Galactosylceramide Leads to Vaccine-Associated Enhanced Respiratory Disease in Influenza-Vaccinated Pigs. MDPI AG.
Chicago Style (17th ed.) CitationArtiaga, Bianca L., et al. Adjuvant Use of the Invariant-Natural-Killer-T-Cell Agonist α-Galactosylceramide Leads to Vaccine-Associated Enhanced Respiratory Disease in Influenza-Vaccinated Pigs. MDPI AG.
MLA (9th ed.) CitationArtiaga, Bianca L., et al. Adjuvant Use of the Invariant-Natural-Killer-T-Cell Agonist α-Galactosylceramide Leads to Vaccine-Associated Enhanced Respiratory Disease in Influenza-Vaccinated Pigs. MDPI AG.
Warning: These citations may not always be 100% accurate.